NZ186075A - 2-methoxybenzamide derivatives, and pharmaceutical compositions containing them - Google Patents

2-methoxybenzamide derivatives, and pharmaceutical compositions containing them

Info

Publication number
NZ186075A
NZ186075A NZ186075A NZ18607577A NZ186075A NZ 186075 A NZ186075 A NZ 186075A NZ 186075 A NZ186075 A NZ 186075A NZ 18607577 A NZ18607577 A NZ 18607577A NZ 186075 A NZ186075 A NZ 186075A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
compositions containing
methoxybenzamide
derivatives
methoxybenzamide derivatives
Prior art date
Application number
NZ186075A
Inventor
H Najer
Bm Raizon
Jpe Kaplan
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7639033A external-priority patent/FR2375167A1/en
Priority claimed from FR7639034A external-priority patent/FR2378520A1/en
Application filed by Synthelabo filed Critical Synthelabo
Publication of NZ186075A publication Critical patent/NZ186075A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
NZ186075A 1976-12-24 1977-12-22 2-methoxybenzamide derivatives, and pharmaceutical compositions containing them NZ186075A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7639033A FR2375167A1 (en) 1976-12-24 1976-12-24 N-1-enzyl-2-pyrrolidinyl-methyl 2-methoxy-benzamide derivs. - esp. the 5-sulphamoyl-benzamide cpds., are psychotropics and neuroleptics
FR7639034A FR2378520A1 (en) 1976-12-24 1976-12-24 N-1-enzyl-2-pyrrolidinyl-methyl 2-methoxy-benzamide derivs. - esp. the 5-sulphamoyl-benzamide cpds., are psychotropics and neuroleptics

Publications (1)

Publication Number Publication Date
NZ186075A true NZ186075A (en) 1979-11-01

Family

ID=26219761

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ186075A NZ186075A (en) 1976-12-24 1977-12-22 2-methoxybenzamide derivatives, and pharmaceutical compositions containing them

Country Status (14)

Country Link
JP (1) JPS5382771A (en)
AU (1) AU3192177A (en)
DE (1) DE2757406A1 (en)
DK (1) DK575877A (en)
ES (1) ES465366A2 (en)
FI (1) FI773911A (en)
GB (1) GB1556566A (en)
GR (1) GR66082B (en)
IL (1) IL53680A0 (en)
LU (1) LU78773A1 (en)
NL (1) NL7714301A (en)
NO (1) NO774402L (en)
NZ (1) NZ186075A (en)
SE (1) SE7714659L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3005722A1 (en) * 1980-02-15 1981-08-20 Bayer Ag, 5090 Leverkusen TRIFLUORMETHYLBENE CYL ESTER, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF IN PEST CONTROL
CA1157884A (en) * 1980-04-16 1983-11-29 Byron R. Cotter Process for the preparation of trifluoromethylbenzoyl halides

Also Published As

Publication number Publication date
GB1556566A (en) 1979-11-28
SE7714659L (en) 1978-06-25
AU3192177A (en) 1979-06-28
FI773911A (en) 1978-06-25
GR66082B (en) 1981-01-15
NO774402L (en) 1978-06-27
LU78773A1 (en) 1979-07-20
JPS5382771A (en) 1978-07-21
DK575877A (en) 1978-06-25
IL53680A0 (en) 1978-03-10
DE2757406A1 (en) 1978-06-29
ES465366A2 (en) 1978-09-16
NL7714301A (en) 1978-06-27

Similar Documents

Publication Publication Date Title
NZ183616A (en) Acetohydroxamic derivatives,and pharmaceutical compositions
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL53043A (en) N-heterocyclylalkyl-(1-aryloxy-2-hydroxy-3-amino-propane)derivatives,their preparation and pharmaceutical compositions containing them
NZ183150A (en) 7-aminothiazolyl-iminoa-cetamido-cephalosporin derivatives and pharmaceutical compositions
IL51403A (en) 5-diazinyl-1,2-dithiole-3-thione derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL56017A (en) 5-cyano-prostacyclin derivatives,their manufacture and pharmaceutical compositions containing them
IL52337A (en) Dipeptide derivatives,their manufacture and pharmaceutical compositions containing them
IL49325A (en) 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them
NZ184755A (en) 2-benzylpyrrolidine derivatives and pharmaceutical compositions
IL52307A (en) Dipeptide derivatives,their manufacture and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
IL52717A (en) Derivatives of2-phenylamino-imidazoline-(2),their preparation and pharmaceutical compositions containing them
IL52857A (en) Oxo-benzopyrane derivatives,their preparation and pharmaceutical compositions containing them
NZ185642A (en) Morphanthridine derivatives and pharmaceutical compositions
IL52137A (en) N-heterocyclic-n-(hetero)arylfluoroalkylamines,their preparation and pharmaceutical compositions containing them
IL53926A0 (en) New oxadiazolopyrimidine derivatives, their manufacture and pharmaceutical compositions containing them
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ184103A (en) Fenzodioxole derivatives and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
IL51468A (en) 17 -hydroxy- -d-homosteroid derivatives,their preparation and pharmaceutical compositions containing them
NZ185267A (en) Derivatives of 1-amino-2hydroxy-3-heterocycloxy-propanes, and pharmaceutical compositions containing them
IL53146A0 (en) Pharmaceutical compositions containing certain pyrrolidone derivatives
NZ185295A (en) 9-chloroprednisolone derivatives and pharmaceutical compositions
NZ184367A (en) 2-vinyl-chromone derivatives and pharmaceutical compositions
NZ184647A (en) 3-phenoxy-1,2-bis-aminoe-thoxypropane derivatives and pharmaceutical compositions